Gabapentin Capsule
Product Images NDC 71335-2381

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71335-2381). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Gabapentincapsules 01)

The formula provided calculates creatinine clearance (CLCr) using the patient's age and weight for males, and age, weight, and a correction factor for females. This equation is commonly used to estimate kidney function in clinical settings.*

FDA Label Image

Chemical Structure (Gabapentincapsules 02)

FDA Label Image

Figure 1 (Gabapentincapsules 03)

Mean Pain Score 0, compared to placebo and Gabapentin 3600 mg/day. Evaluation at weeks 1, 2, 3, 4, 5, and 6.*

FDA Label Image

Figure 2 (Gabapentincapsules 04)

FDA Label Image

Figure 3 (Gabapentincapsules 05)

FDA Label Image

Figure 4 (Gabapentincapsules 06)

FDA Label Image

Label (Lbl713352381)

Each capsule contains: Gabapentin USP 400mg. Keep this and all drugs out of the reach of children, Gabapentin Capsules, USP. Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F). May cause dizziness. Rx only. 90 Capsules. Repackaged by Bryant Ranch Prepack, Inc. Manufactured by Zhejiang Yongtai Pharmaceutical Co. Website: https://dailymed.nIim.nih.gov/dailymed/ HIDAN, armacetfica I.otd.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.